Event: ESC Congress 2021 - The Digital Experience
Topic: Risk Factors and Prevention
Session: Exploring the latest evidence of cardiovascular benefits with glucagon-like peptide 1 receptor agonists
Event: ESC Congress 2019
Topic: Diabetes and the Heart
Session: GLP-1 Receptor agonists – Pioneers of further cardiovascular risk reduction in diabetes?
Event: ESC Congress 2018
Topic: Pharmacotherapy
Session: Diabetes, adiposity and metabolic syndrome
Event: ESC Congress 2018
Topic: Diabetes and the Heart
Session: Joining clinical practices: cardiovascular disease and type 2 diabetes
Event: ESC Congress 2018
Topic: Diabetes and the Heart
Session: Joining clinical practices: cardiovascular disease and type 2 diabetes
Event: ESC Congress 2017
Topic: Diabetes, dysglycaemia and metabolic syndrome
Session: GLP-1 receptor agonists and cardiovascular risk management in type 2 diabetes: a new treatment paradigm?
Event: ESC Congress 2017
Topic: Diabetes, dysglycaemia and metabolic syndrome
Session: GLP-1 receptor agonists and cardiovascular risk management in type 2 diabetes: a new treatment paradigm?
Event: ESC Congress 2016
Topic: Diabetes management
Session: Addressing cardiovascular risk in type 2 diabetes - The LEADER trial